The Legal Intelligencer | News
By Justin Henry | May 25, 2021
The firm also saw another attorney leave this week to go in-house at a pharma company.
The Legal Intelligencer | News
By Ellen Bardash | May 5, 2021
The settlement resolves a whistleblower case filed in the Eastern District of Pennsylvania and against the Wilmington, Delaware-headquartered company, accused of donating to a foundation and using those funds toward the copays of Medicare and TRICARE beneficiaries who weren't eligible for coverage of Incyte Corp.'s drug, Jakafi.
By Charles Toutant | April 28, 2021
"If I'm trying a case against Moderna [a developer of a COVID-19 vaccine], there's going to be a positive impression and you're going to have to deal with it," said Christopher Placitella, a drug defect lawyer at Cohen, Placitella & Roth in Red Bank, New Jersey.
The Legal Intelligencer | News
By Max Mitchell | April 13, 2021
The potential outcomes in the Keystone Rx case include striking down parts of the Workers' Compensation Act, or allowing pharmacies to participate in the so-called utilization review process.
Connecticut Law Tribune | News
By Robert Storace | February 4, 2021
Forty-seven states reached the settlement with global consulting firm McKinsey & Co. over its work on behalf of opioid makers.
By Amanda Bronstad | January 22, 2021
On Friday, U.S. District Judge Brian Martinotti of the District of New Jersey approved a leadership team of 25 plaintiffs lawyers, 18 of whom are women, to spearhead 140 lawsuits alleging Janssen's pharmaceutical drug Elmiron causes eye problems.
By Tom McParland | January 8, 2021
U.S. District Judge Denise L. Cote of the Southern District of New York rejected Shkreli's long-shot bid to stay discovery in the case, which was filed last January by the Federal Trade Commission and seven states, including New York.
By Amanda Bronstad | December 16, 2020
In a Tuesday order, the U.S. Judicial Panel on Multidistrict Litigation appointed U.S. District Judge Brian Martinotti to oversee the lawsuits, which allege that Elmiron, used to treat chronic bladder infection called interstitial cystitis, causes eye problems.
The Legal Intelligencer | News
By Max Mitchell | November 9, 2020
As attorneys across the country fight over whether to consolidate litigation over the bladder infection medication Elmiron into a single federal court, a district judge in Pennsylvania has decided that claims seeking medical monitoring over the medication can't be litigated as a national class action.
By Amanda Bronstad | November 5, 2020
The proposal, which still has to be approved by thousands of cities and counties, may have overcome a major hurdle in the negotiations for a global opioid settlement: legal fees. The deal involves three major pharmaceutical distributors and Johnson & Johnson.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
The premier educational and networking event for employee benefits brokers and agents.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS